Journal article icon

Journal article

Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.

Abstract:

Olanzapine was licensed in the USA by the Food and Drug Administration in 2003 for the prevention of relapse in patients with bipolar disorder when the acute manic episode had responded to treatment with olanzapine. However, olanzapine is commonly used in clinical practice for preventing relapse in patients with bipolar disorder even when acute response has not been demonstrated. The aim of this systematic review and meta-analysis is to determine the effectiveness and acceptability of olanzap...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1177/0269881109106900

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Psychiatry
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Psychiatry
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Psychiatry
Role:
Author
Journal:
Journal of psychopharmacology (Oxford, England)
Volume:
24
Issue:
12
Pages:
1729-1738
Publication date:
2010-12-05
DOI:
EISSN:
1461-7285
ISSN:
0269-8811
URN:
uuid:3ecc696b-85c2-41d0-90c4-749ad4cbe1ed
Source identifiers:
127585
Local pid:
pubs:127585

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP